TOR Serine-Threonine Kinases
1 clinical trials · Condition
◉ Watch TOR Serine-Threonine Kinases
| Record | Firm | Date |
|---|---|---|
| Everolimus in Selected Patients With Metastatic Melanoma: Efficacy and Safety Study (NCT01960829) | Peking University Cancer Hospital & Institute | 2013-09-01 |
Track TOR Serine-Threonine Kinases automatically
Every clearance here is in the API, with alerts when new ones post.